These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2107740)

  • 1. Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
    Garner SS; Wiest DB
    Am J Hosp Pharm; 1990 Mar; 47(3):604-6. PubMed ID: 2107740
    [No Abstract]   [Full Text] [Related]  

  • 2. Administrating incompatible drugs by a retrograde intravenous infusion system.
    Johnson CE; Roesner MP; Berman JR; Burch KJ
    Am J Hosp Pharm; 1985 Jan; 42(1):109-11. PubMed ID: 2982257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compatibility problems in intensive care medicine].
    Schröder F
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):52-8. PubMed ID: 8173313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments: i.v. drug compatibility.
    Drug Intell Clin Pharm; 1986 Sep; 20(9):714-5. PubMed ID: 3757789
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mixtures of infusion solutions and drugs. Compatibility and incompatibility].
    Pecar A; Dirks B
    Anaesthesist; 1995 Nov; 44(11):793-803. PubMed ID: 8678272
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of paclitaxel (Taxol) administration, stability, and compatibility issues.
    Boyle DA; Goldspiel BR
    Clin J Oncol Nurs; 1998 Oct; 2(4):141-5. PubMed ID: 10232160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of drugs with a heparin-containing neonatal total parenteral nutrient solution.
    Schilling CG
    Am J Hosp Pharm; 1988 Feb; 45(2):313-4. PubMed ID: 3129935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion.
    Ishisaka DY; Van Vleet J; Marquardt E
    Am J Hosp Pharm; 1991 Nov; 48(11):2442-3. PubMed ID: 1746582
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of total nutrient admixtures and secondary antibiotic infusions.
    Baptista RJ; Lawrence RW
    Am J Hosp Pharm; 1985 Feb; 42(2):362-3. PubMed ID: 3919577
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin.
    Lee YC; Malick AW; Amann AH; Baaske DM; Shah JJ; Wagenknecht DM; Carter JE
    Am J Hosp Pharm; 1981 Feb; 38(2):183-7. PubMed ID: 6782870
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of fluconazole with drugs given by continuous infusion.
    Ishisaka DY
    Am J Hosp Pharm; 1994 Sep; 51(18):2290, 2292. PubMed ID: 7801993
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.